Abstract
In the last few decades, obesity has captured the attention of the medical community, as well as the general public. Obesity has been shown to be a direct cause or a contributor to the development of various chronic diseases. In contrast, higher weight has been linked to better outcomes in patients with chronic obstructive pulmonary disease (COPD). It also has been recognized that “not all weight has been created equal” and its not the absolute weight in kilograms or the body-mass index (BMI), but rather the fat-free mass index (FFMI) that is a better measure of the nutritional status and the overall prognosis in COPD patients. While the impact of the weight and the nutritional status on the lung cancer outcomes has been similar to that of COPD, the relationship between the obesity and asthma has been more complex and multi-faceted. The article will offer a concise, rather than a comprehensive review of such relationships between the nutritional status and the natural history of three chronic lung diseases. The effects of nutritional supplements, alternative medications, and other interventions will be discussed in the context of the individual diseases (COPD, asthma and lung cancer).
Keywords: Obesity, COPD, asthma, lung cancer, body mass index, fat free mass index
Current Respiratory Medicine Reviews
Title: Obesity in the Patient with Lung Disease
Volume: 4 Issue: 2
Author(s): Zaza I. Cohen
Affiliation:
Keywords: Obesity, COPD, asthma, lung cancer, body mass index, fat free mass index
Abstract: In the last few decades, obesity has captured the attention of the medical community, as well as the general public. Obesity has been shown to be a direct cause or a contributor to the development of various chronic diseases. In contrast, higher weight has been linked to better outcomes in patients with chronic obstructive pulmonary disease (COPD). It also has been recognized that “not all weight has been created equal” and its not the absolute weight in kilograms or the body-mass index (BMI), but rather the fat-free mass index (FFMI) that is a better measure of the nutritional status and the overall prognosis in COPD patients. While the impact of the weight and the nutritional status on the lung cancer outcomes has been similar to that of COPD, the relationship between the obesity and asthma has been more complex and multi-faceted. The article will offer a concise, rather than a comprehensive review of such relationships between the nutritional status and the natural history of three chronic lung diseases. The effects of nutritional supplements, alternative medications, and other interventions will be discussed in the context of the individual diseases (COPD, asthma and lung cancer).
Export Options
About this article
Cite this article as:
Cohen I. Zaza, Obesity in the Patient with Lung Disease, Current Respiratory Medicine Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339808784222803
DOI https://dx.doi.org/10.2174/157339808784222803 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in the Development of Anticancer HSP-based Vaccines
Current Medicinal Chemistry Kinetic Data of D-Glyceraldehyde-3-Phosphate Dehydrogenase from HeLa Cells
Current Enzyme Inhibition Gene Therapy Using an Adenovirus Vector for Apoptosis-Related Genes is a Highly Effective Therapeutic Modality for Killing Glioma Cells
Current Gene Therapy Plasma-Rich in Growth Factor and its Clinical Application
Current Stem Cell Research & Therapy Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review
Reviews on Recent Clinical Trials Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part I: Xanthones, Quinones, Steroids, Coumarins, Phenolics and other Classes of Compounds
Anti-Cancer Agents in Medicinal Chemistry Expression Profiles and Bioinformatics Analysis of Full-length circRNA Isoforms in Gliomas
Current Bioinformatics Cancer Stem Cells: Current Status and Therapeutic Implications in Cancer Therapy-A New Paradigm
Current Stem Cell Research & Therapy Immune Checkpoint Regulators: A New Era Toward Promising Cancer Therapy
Current Cancer Drug Targets Red Blood Cell-Encapsulated L-Asparaginase: Potential Therapy of Patients with Asparagine Synthetase Deficient Acute Myeloid Leukemia
Protein & Peptide Letters Stem Cell and Idiopathic Pulmonary Fibrosis: Mechanisms and Treatment
Current Stem Cell Research & Therapy Microwave Synthesis of Guanine and Purine Analogs
Current Microwave Chemistry Vitamin E - Occurrence, Biosynthesis by Plants and Functions in Human Nutrition
Mini-Reviews in Medicinal Chemistry Cancer Invasion and Metastasis: Discovering New Targets For Diagnosis and Therapeutics
Current Signal Transduction Therapy Dietary Polyphenols for Prostate Cancer Therapy
Current Bioactive Compounds Synthesis and Evaluation of Anti-Inflammatory and Antitussive Activity of Hydantion Derivatives
Letters in Drug Design & Discovery Dietary Prevention of Cancer: Anticancer and Antiangiogenic Properties of Green Tea Polyphenols
Medicinal Chemistry Reviews - Online (Discontinued) <i>In Vitro</i> and <i>In Vivo</i> Evaluation of Novel DTX-Loaded Multifunctional Heparin-Based Polymeric Micelles Targeting Folate Receptors and Endosomes
Recent Patents on Anti-Cancer Drug Discovery AG490 Promotes HIF-1α Accumulation by Inhibiting Its Hydroxylation
Current Medicinal Chemistry Development of Taxol and Other Endophyte Produced Anti-Cancer Agents
Recent Patents on Anti-Cancer Drug Discovery